Showing 801 - 820 results of 1,061 for search '"lymphoma"', query time: 0.04s Refine Results
  1. 801

    Outcome differences by sex in oncology clinical trials by Ashwin V. Kammula, Alejandro A. Schäffer, Padma Sheila Rajagopal, Razelle Kurzrock, Eytan Ruppin

    Published 2024-03-01
    “…The strongest differences are in trials of EGFR inhibitors in lung cancer and rituximab in non-Hodgkin’s lymphoma (both favoring females). Among 44 trials with side effect comparisons, more trials report significantly lesser side effects in males (N = 22) than in females (N = 13). …”
    Get full text
    Article
  2. 802

    Helicobacter pylori Infection and Gastric Dysbiosis: Can Probiotics Administration Be Useful to Treat This Condition? by Giovanni Bruno, Giulia Rocco, Piera Zaccari, Barbara Porowska, Maria Teresa Mascellino, Carola Severi

    Published 2018-01-01
    “…It is considered a major pathogenic agent of chronic gastritis, peptic ulcer, atrophic gastritis, gastric cancer, and mucosa-associated lymphoid tissue lymphoma (MALT). Hp colonization modifies the composition of gastric microbiota that could drive the development of gastric disorders. …”
    Get full text
    Article
  3. 803
  4. 804

    A Case of Relapsing Kikuchi-Fujimoto Disease by Talayeh Rezayat, Matthew B. Carroll, Bryan C. Ramsey, Andria Smith

    Published 2013-01-01
    “…KFD can mimic other serious conditions such as lymphoma, systemic lupus erythematosus (SLE), herpes simplex, and Epstein Barr virus. …”
    Get full text
    Article
  5. 805

    Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis by Dania Khoulani, Bharat Rao, Ammar Khanshour, Philip Kuriakose, Lenar Yessayan

    Published 2014-01-01
    “…We here report the failure of rFVIIa to control DAH in a patient with CD5+ B-cell non-Hodgkin’s lymphoma and cryoglobulinemic vasculitis.…”
    Get full text
    Article
  6. 806

    Septic Shock Induced by Bacterial Prostatitis with Morganella morganii subsp. morganii in a Posttransplantation Patient by Xiaofan Li, Jianhui Chen

    Published 2015-01-01
    “…He received HLA-matched sibling allo-HSCT because of angioimmunoblastic T-cell lymphoma 29 months ago. The routine examination of prostatic fluid showed increased leukocytes and the culture of prostatic fluid showed Morganella morganii subsp. morganii. …”
    Get full text
    Article
  7. 807

    Clinical Trials of Immunogene Therapy for Spontaneous Tumors in Companion Animals by Gerardo Claudio Glikin, Liliana María Elena Finocchiaro

    Published 2014-01-01
    “…A variety of tumors such as canine melanoma, soft tissue sarcomas, osteosarcoma and lymphoma, feline fibrosarcoma, and equine melanoma were subjected to different treatment approaches. …”
    Get full text
    Article
  8. 808

    A systematic review of contemporary phase I trials in patients with recurrent/metastatic head and neck cancer by V.G. Espeli, A. Gomez, P. Balermpas, G. Treglia, A. Stathis

    Published 2024-09-01
    “…PubMed and Cochrane Library databases were searched using a combination of terms: “((head and neck) OR (head & neck)) AND ((cancer*) OR (tumor*) OR (tumour*) OR (neoplasm*) OR (carcinoma*) OR (malignan*)) AND ((phase 1) OR (phase I))''to identify phase I dose-finding trials including a majority of lymphoma patients.Eighty-five trials (H&N patients N = 1714) were included. …”
    Get full text
    Article
  9. 809

    Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition? by Jean-François Viallard, Marie Parrens, Frédéric Rieux-Laucat

    Published 2019-01-01
    “…We report the case of a young woman who developed, 3 years after stopping Rituximab (RTX) prescribed for immune thrombocytopenia (ITP), a severe immunodeficiency leading to fatal pulmonary Epstein–Barr virus-positive diffuse large B-cell lymphoma. Genetic analysis led us to identify four missense mutations known to affect immune-deficiency–associated genes (FAS-ligand (FASL) gene (p.G167R); perforin-1 (PRF1 (p.R55C) gene; the Bloom syndrome RecQ-Like helicase (BLM) gene and the Moesin (MSN) (p.A122T) gene). …”
    Get full text
    Article
  10. 810

    Niemann-pick disease with visceral and pulmonary involvement in a resource limited setting: A rare case report by Eyasu Wakjira Korsa, MD, Samuel Sisay Hailu, MD, Hewan Asfaw, MD, Hanna Damtew, MD, Daniel Zewdneh Solomon, MD

    Published 2025-03-01
    “…This case highlights the diagnostic challenges of rare disease in resource-limited settings, often mistaken for more common conditions like tuberculosis and lymphoma.…”
    Get full text
    Article
  11. 811

    Anti-Müllerian Hormone as a Sensitive Marker of Ovarian Function in Young Cancer Survivors by Maryna Krawczuk-Rybak, Elzbieta Leszczynska, Marta Poznanska, Beata Zelazowska-Rutkowska, Jolanta Wysocka

    Published 2013-01-01
    “…The lowest AMH values were noted in patients after bone marrow transplantation (BMT) and those treated for Hodgkin lymphoma (HL). Nineteen patients (22.9%) had elevated FSH. …”
    Get full text
    Article
  12. 812

    Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties by Koji Kawakami, Oumi Nakajima, Ryuichi Morishita, Ryozo Nagai

    Published 2006-01-01
    “…Two agents, DAB389IL-2 (ONTAKTM) targeting the interleukin-2 receptor and CD33-calicheamicin (Mylotarg®), have been approved by the FDA for cutaneous T-cell lymphoma (CTCL) and relapsed acute myeloid leukemia (AML), respectively. …”
    Get full text
    Article
  13. 813

    Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies – a systematic review by Aleksandra Janowiak-Majeranowska, Gazala Abdulaziz-Opiela, Jakub Osowski, Bogusław Mikaszewski

    Published 2024-07-01
    “…The systematic review included a total of 77 patients, the majority of whom had Hodgkin’s lymphoma (65 patients, 84.4%). Only one patient had leukemia. …”
    Get full text
    Article
  14. 814

    In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead? by Carlotta Mattioda, Claudia Voena, Gianluca Ciardelli, Clara Mattu

    Published 2025-01-01
    “…Haematological malignancies comprise a diverse group of life-threatening systemic diseases, including leukaemia, lymphoma, and multiple myeloma. Currently available therapies, including chemotherapy, immunotherapy, and CAR-T cells, are often associated with important side effects and with the development of drug resistance and, consequently, disease relapse. …”
    Get full text
    Article
  15. 815

    Chronic Lymphocytic Leukemia and Myelofibrosis by Fares Darawshy, Arieh Ben-Yehuda, Karine Atlan, Deborah Rund

    Published 2018-01-01
    “…Chronic lymphocytic lymphoma (CLL) can be associated with several malignancies, but rarely with myelofibrosis. …”
    Get full text
    Article
  16. 816

    Secondary amyloidosis with concomitant gastric GIST and gastric adenocarcinoma - A case report by Ankita Soni, Nishant Batta, Shefali Mehmi, Vikram Narang, Bhavna Garg, Harpreet Kaur

    Published 2023-07-01
    “…., It has also been reported in association with neoplasms such as Hodgkin's lymphoma, Waldenstrom's macroglobulinemia, renal cell carcinoma, lung carcinoma, etc. …”
    Get full text
    Article
  17. 817

    Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation by Ömür Gökmen Sevindik, İnci Alacacıoğlu, Abdullah Katgı, Şerife Medeni Solmaz, Celal Acar, Özden Pişkin, Mehmet Ali Özcan, Fatih Demirkan, Bülent Ündar, Güner Hayri Özsan

    Published 2015-01-01
    “…We report a 43-year-old male patient who was diagnosed as TA-TMA after allogeneic progenitor cell transplantation for a progressive ALK negative anaplastic large cell lymphoma and responded to eculizumab with dramatically improving neurological status and renal function. …”
    Get full text
    Article
  18. 818

    Bio-mimetic strategies to re-activate apoptotic cell death for cancer treatments by Andrea Venerando, Denise Lovison, Rossella De Marco

    Published 2024-11-01
    “…The internal (or mitochondrial) and external (or death receptor) pathways are responsible for driving a series of molecular events that lead to apoptosis by releasing pro-apoptotic proteins, such as B-cell lymphoma-2 (BCL-2) homology 3 (BH3)-only proteins and second mitochondria-derived activator of caspases/diablo inhibitor of apoptosis protein-binding mitochondrial protein (SMAC/DIABLO), that in turn activate the caspase family of proteases. …”
    Get full text
    Article
  19. 819

    Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus by Julio Alonso-Padilla, Esther M. Lafuente, Pedro A. Reche

    Published 2017-01-01
    “…EBV infection is also linked to various cancers, including Burkitt’s lymphoma and nasopharyngeal carcinomas, and autoimmune diseases such as multiple sclerosis. …”
    Get full text
    Article
  20. 820

    Acute Left Internal Carotid Artery and Right Popliteal Artery Occlusion Related to Cisplatin-Gemcitabine Based Chemotherapy by Saman Zafar, Rashmika Potdar, Andrew Tiu, Gabor Varadi, John Leighton

    Published 2018-01-01
    “…We report a case of a 64-year-old male with Diffuse Large B-Cell Non-Hodgkin’s Lymphoma who presented with left-sided headache and right calf pain two weeks after starting Rituximab/Gemcitabine/Cisplatin/Dexamethasone chemotherapy. …”
    Get full text
    Article